Published in Biotech Business Week, January 9th, 2006
The studies will focus on the physical structure and genetic makeup of two different tick-borne bacteria, and will yield important information concerning their ability to establish infection and cause disease in human hosts.
"These projects will utilize cutting-edge laboratory techniques to help develop our understanding of two important human pathogens," said Leo J. Shea, III, PhD, chairman of the NRFTD board of directors. "The data yielded will be of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.